微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 14.22% | -18.1% | -0.72% | 120/132 | 51.53% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 14.33% | -17.15% | -2.01% | 122/132 | 51.65% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 14.62% | -10.86% | -17.85% | 121/132 | 51.25% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 17.8% | -16.48% | 2.47% | 119/132 | 52.33% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 17.37% | -19.54% | 0.44% | 117/132 | 53.25% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 17.29% | -18.69% | 5.42% | 119/132 | 53.3% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 16.4% | -20.39% | -23.03% | 118/132 | 53.43% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 21.31% | -4.96% | -1.27% | 116/132 | 53.31% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 21.59% | 2% | 1.5% | 111/132 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 21.27% | 5.43% | 3.21% | 115/132 | 53.45% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 20.6% | 7.25% | -8.11% | 112/132 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 22.42% | -0.62% | 5.96% | 117/132 | 53.83% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 21.16% | 2% | 4.92% | 112/132 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 20.17% | -5.58% | 4.99% | 117/132 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 19.21% | 2% | -14.86% | 107/132 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 22.56% | 10.93% | 5.62% | 120/132 | 57.29% | 三友医疗 | 90.5% | 行业排名> |
| 2021-06-30 | 21.36% | 2.98% | 5.03% | 113/132 | 58.42% | 三友医疗 | 90.29% | 行业排名> |
| 2020-12-31 | 20.34% | -8.07% | -1.95% | 123/132 | 59.59% | 正海生物 | 90.78% | 行业排名> |
| 2020-06-30 | 20.74% | 2% | -6.24% | 107/132 | 59.94% | 正海生物 | 91.59% | 行业排名> |
| 2019-12-31 | 22.12% | 13.57% | 13.57% | 111/132 | 56.37% | 正海生物 | 92.23% | 行业排名> |
| 2018-12-31 | 19.48% | -19.99% | -19.99% | 109/132 | 55.53% | 正海生物 | 92.69% | 行业排名> |
| 2017-12-31 | 24.35% | 2% | 2% | 100/132 | 55.34% | 正海生物 | 92.61% | 行业排名> |